ArticleJournal of urban health : bulletin of the New York Academy of Medicine2015
Comparison of risk-based hepatitis C screening and the true seroprevalence in an urban prison system.
Article in Journal of urban health : bulletin of the New York Academy of Medicine, 2015. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 19 papers, 3 of them syntheses that pooled it.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
19 citing papers in PubMed, 3 syntheses or guidelines pooled it.
- Hepatitis C prevalence in incarcerated settings between 2013-2021: a systematic review and meta-analysis.BMC public health · 2022Pooled it
- Hepatitis C Guidance 2019 Update: American Association for the Study of Liver Diseases-Infectious Diseases Society of America Recommendations for Testing, Managing, and Treating Hepatitis C Virus Infection.Hepatology (Baltimore, Md.) · 2020Guideline
- Active Case Finding for Communicable Diseases in Prison Settings: Increasing Testing Coverage and Uptake Among the Prison Population in the European Union/European Economic Area.Epidemiologic reviews · 2018Pooled it
- Estimates of Hepatitis C Seroprevalence and Viremia in State Prison Populations in the United States.The Journal of infectious diseases · 2023Article
- Article
- The Importance of Prisons in Achieving Hepatitis C Elimination: Insights from the Australian Experience.Viruses · 2022Article
- Seroprevalence and associated factors of HIV and Hepatitis C in Brazilian high-security prisons: A state-wide epidemiological study.PloS one · 2021Article
- The hepatitis C virus care cascade in the New York City jail system during the direct acting antiviral treatment era, 2014-2017.EClinicalMedicine · 2020Article
- A simple risk-based strategy for hepatitis C virus screening among incarcerated people in a low- to middle-income setting.Harm reduction journal · 2020Article
- Opioid epidemic and liver disease.JHEP reports : innovation in hepatology · 2019Review
- Evaluating peer-supported screening as a hepatitis C case-finding model in prisoners.Harm reduction journal · 2019Observational
- Testing for Hepatitis C in Pregnancy: the Time has Come for Routine Rather than Risk-based.Current hepatology reports · 2019Article
- Estimating Prevalence of Hepatitis C Virus Infection in the United States, 2013-2016.Hepatology (Baltimore, Md.) · 2019Review
- Hepatitis C virus (HCV) care in Canadian correctional facilities: Where are we and where do we need to be?Canadian liver journal · 2019Review
- Hepatitis C Guidance 2018 Update: AASLD-IDSA Recommendations for Testing, Managing, and Treating Hepatitis C Virus Infection.Clinical infectious diseases : an official publication of the Infectious Diseases Society of America · 2018Article
- Hepatitis C Cascade of Care Among Pregnant Women on Opioid Agonist Pharmacotherapy Attending a Comprehensive Prenatal Program.Maternal and child health journal · 2017Article
- Clinical care of incarcerated people with HIV, viral hepatitis, or tuberculosis.Lancet (London, England) · 2016Review
- Correlates of Hepatitis C Virus Infection in the Targeted Testing Program of the New York City Jail System.Public health reports (Washington, D.C. : 1974)Article
- Hepatitis C Virus Testing and Linkage to Care in North Carolina and South Carolina Jails, 2012-2014.Public health reports (Washington, D.C. : 1974)Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
Abstract
Hepatitis C virus (HCV) is the most common blood-borne infection in the USA, though seroprevalence is elevated in certain high-risk groups such as inmates. Correctional facility screening protocols vary from universal testing to opt-in risk-based testing. This project assessed the success of a risk-based HCV screening strategy in the Philadelphia Prison System (PPS) by comparing results from current testing practices during 2011-2012 (Risk-Based Screening Group) to a September 2012 blinded seroprevalence study (Philadelphia Department of Public Health (PDPH) Study Cohort). PPS processed 51,562 inmates in 2011-2012; 2,727 were identified as high-risk and screened for HCV, of whom 57 % tested HCV antibody positive. Twelve percent (n = 154) of the 1,289 inmates in the PDPH Study Cohort were anti-HCV positive. Inmates ≥30 years of age had higher rates of seropositivity in both groups. Since only 5.3 % of the prison population was included in the Risk-Based Screening Group, an additional 4,877 HCV-positive inmates are projected to have not been identified in 2011-2012. Gaps in case identification exist when risk-based testing is utilized by PPS. A more comprehensive screening model such as opt-out universal testing should be considered to identify HCV-positive inmates. Identification of these individuals is an important opportunity to aid underserved high-risk populations and to provide medical care and secondary prevention.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.